NeuroPace Inc (NPCE) stock
NPCENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/3029% above fair value
$8.22+0.02 (+0.24%)
Close on Nov 18, 2026Market cap $282.15MP/E –Yield 0.00%
NeuroPace gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
NeuroPace's gross profit for the twelve months ending Jun 30, 2026 was $78.70M, up 20.8% year over year. For fiscal 2025 it was $77.22M, up 30.7% from the year before. The highest annual figure on record is $77.22M in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $77.22M | +30.7% |
| FY2024 | Dec 31, 2024 | $59.09M | +22.8% |
| FY2023 | Dec 31, 2023 | $48.12M | +48.1% |
| FY2022 | Dec 31, 2022 | $32.49M | -2.8% |
| FY2021 | Dec 31, 2021 | $33.44M | +10.4% |
| FY2020 | Dec 31, 2020 | $30.27M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $18.91M | +16.6% |
| Q1 FY2026 | Mar 31, 2026 | $18.05M | +4.1% |
| Q4 FY2025 | Dec 31, 2025 | $20.58M | +27.1% |
| Q3 FY2025 | Sep 30, 2025 | $21.17M | +37.3% |
| Q2 FY2025 | Jun 30, 2025 | $16.21M | +14.7% |
| Q1 FY2025 | Mar 31, 2025 | $17.34M | +30.0% |
| Q4 FY2024 | Dec 31, 2024 | $16.19M | +19.5% |
| Q3 FY2024 | Sep 30, 2024 | $15.42M | +26.1% |
| Q2 FY2024 | Jun 30, 2024 | $14.13M | +18.1% |
| Q1 FY2024 | Mar 31, 2024 | $13.34M | +28.6% |
| Q4 FY2023 | Dec 31, 2023 | $13.55M | +53.9% |
| Q3 FY2023 | Sep 30, 2023 | $12.23M | +53.6% |
| Q2 FY2023 | Jun 30, 2023 | $11.97M | +60.4% |
| Q1 FY2023 | Mar 31, 2023 | $10.37M | +25.6% |
| Q4 FY2022 | Dec 31, 2022 | $8.80M | +9.0% |
| Q3 FY2022 | Sep 30, 2022 | $7.97M | +6.1% |
| Q2 FY2022 | Jun 30, 2022 | $7.47M | -20.2% |
| Q1 FY2022 | Mar 31, 2022 | $8.26M | -2.8% |
| Q4 FY2021 | Dec 31, 2021 | $8.08M | -1.7% |
| Q3 FY2021 | Sep 30, 2021 | $7.51M | -21.6% |
| Q2 FY2021 | Jun 30, 2021 | $9.36M | +72.6% |
| Q1 FY2021 | Mar 31, 2021 | $8.49M | +20.3% |
| Q4 FY2020 | Dec 31, 2020 | $8.22M | – |
| Q3 FY2020 | Sep 30, 2020 | $9.58M | – |
| Q2 FY2020 | Jun 30, 2020 | $5.42M | – |
| Q1 FY2020 | Mar 31, 2020 | $7.06M | – |
See a number that looks wrong?